|
Cohance Lifesciences Ltd.
|
Cash Flow
|
|
|
You can view the
Cash Flow
for the last 5 years.
|
Market Cap. (Rs.)
|
17599.48 Cr.
|
P/BV
|
4.55
|
Book Value (Rs.)
|
101.05
|
|
52 Week High/Low (Rs.)
|
1039/267
|
FV/ML
|
1/1
|
P/E(X)
|
98.20
|
|
Bookclosure
|
09/08/2024
|
EPS (Rs.)
|
4.68
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 207.04 | 343.92 | 405.67 | 559.73 | 667.59 |
| | | | | | |
| Net CashFlow From Operating Activities | 368.32 | 288.16 | 358.48 | 450.91 | 330.00 |
| Net Cash Used In Investing Activities | -254.57 | -255.30 | -362.25 | -194.84 | -136.21 |
| Net Cash Used From Financing Activities | -165.15 | 3.32 | -13.80 | -235.83 | -156.41 |
| Foreign Exchange Gains / Losses | 3.89 | 1.99 | 0.00 | 0.00 | 0.00 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -47.51 | 38.17 | -17.57 | 20.24 | 37.38 |
| Cash And Cash Equivalents Begin of Year | 96.65 | 47.23 | 64.80 | 44.56 | 7.18 |
| Cash And Cash Equivalents End Of Year | 49.14 | 85.40 | 47.23 | 64.80 | 44.56 |
